HealthCap
Overview
HealthCap is a European venture capital firm investing globally in life sciences. The firm has raised eight funds since 1996 and has backed and built more than 130 companies, taken more than 45 companies public, and completed numerous trade sales. HealthCap's investment strategy focuses on diseases with a high unmet medical need and breakthrough therapies that have the potential to be transformative, change clinical practice, and change the lives of patients suffering from these conditions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hemab Therapeutics | Oct 2025 | Series C | Co-investor |
| Pulmonx | Dec 2014 | Series E | Co-investor |
| Vivet Therapeutics | May 2017 | Series A | Co-investor |
| Aerogen | Mar 2004 | Series A Extension | Co-investor |
| Sesen | Mar 2023 | Reverse Merger | Co-investor |
For institutional investors. Book with your work email.
Key People
Marten Steen
Managing Partner
Georg Vo Beiske
Venture Partner
Björn Odlander
Partner
Carl Kilander
Partner
Daniel Karsberg
Partner
Max Odlander
Partner
Per Samuelsson
Partner
Staffan Lindstrand
Partner
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is HealthCap based?
HealthCap is headquartered in Stockholm, Stockholm County, Sweden.
When was HealthCap founded?
HealthCap was founded in 1996.
How many portfolio companies does HealthCap have?
HealthCap has 26 portfolio companies in Caplight's dataset.
What are some companies in HealthCap's portfolio?
Portfolio companies visible on Caplight include Hemab Therapeutics, Pulmonx, Vivet Therapeutics, Aerogen, Sesen.
What was HealthCap's most recent investment shown here?
HealthCap's most recent investment in this portfolio sample was in Hemab Therapeutics in 2025.
What sectors does HealthCap focus on?
HealthCap focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Enterprise Software.
What company stages does HealthCap focus on?
HealthCap typically invests at the Early stage.
What is HealthCap's AUM?
HealthCap's assets under management are estimated between $1.0B and $10.0B.